Evolus Inc — Quarterly Financial Statistics (NASDAQ:EOLS) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 5.72 M-4.81 M15.63 M24.79 M14.67 M 50.28 M Cash from investing activities 1.41 M1.36 M1.86 M2.27 M2.16 M 7.65 M Cash from financing activities -1.42 M-1.31 M1.63 M17.4 M-1.77 M 15.95 M Free cash flow 4.31 M-6.17 M13.77 M22.52 M12.51 M 42.64 M

Notícias

Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates

Evolus, Inc. (EOLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Boston Scientific (BSX) Beats Q4 Earnings and Revenue Estimates

Mizuho reduz preço-alvo das ações da Evolus para US$ 15 após revisão de projeções

Mizuho lowers Evolus stock price target to $15 on guidance reset

H.C. Wainwright reduz preço-alvo das ações da Evolus para US$ 13 devido a obstáculos no setor estético

H.C. Wainwright lowers Evolus stock price target to $13 on aesthetics headwinds

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday - Callaway Golf (NYSE:CALY), Datadog (NASDAQ:DDOG)

BTIG reduz preço-alvo das ações da Evolus para US$ 13 devido ao declínio do mercado estético

BTIG lowers Evolus stock price target to $13 on aesthetic market decline

Stifel reduz preço-alvo das ações da Evolus para US$ 17 devido à perspectiva de crescimento moderada

Stifel lowers Evolus stock price target to $17 on tempered growth outlook